SA
BSX icon

Seneschal Advisors’s Boston Scientific BSX Stock Holding History

Seneschal Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$299 Hold
7
– – ﹤0.01% 493
2026
Q1 		$440 Sell
7
-2
-22% -$160 ﹤0.01% 394
2025
Q4 		$859 Hold
9
– – ﹤0.01% 255
2025
Q3 		$879 Buy
+9
New +$932 ﹤0.01% 251

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Seneschal Advisors's BSX Position: Q2 2026 in Review

Seneschal Advisors held its Boston Scientific (BSX) position steady in Q2 2026 at 7 shares worth $299. The position accounts for ﹤0.01% of the portfolio, ranked #493.

Seneschal Advisors first reported a position in BSX in Q3 2025 and has held it in 4 quarters since. The position peaked at $879 in Q3 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Seneschal Advisors held 7 shares of Boston Scientific worth $299 as of Q2 2026.
  • Seneschal Advisors left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up ﹤0.01% of Seneschal Advisors's portfolio in Q2 2026, its #493 holding.
  • Seneschal Advisors first reported a position in Boston Scientific in Q3 2025 and has held it in 4 quarters since.
  • Seneschal Advisors's Boston Scientific position peaked at $879 in Q3 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Seneschal Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.